Literature DB >> 19944789

Adjuvantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: different effects on cellular and humoral immunity.

Sumita Ganguly1, Jinyan Liu, Vinod B Pillai, Robert S Mittler, Rama Rao Amara.   

Abstract

Plasmid DNA immunizations induce low levels but a broad spectrum of cellular and humoral immune responses. Here, we investigate the potential of co-stimulation through 4-1BB as an adjuvant for a HIV-1 DNA vaccine in mice. We designed plasmid DNAs expressing either the membrane bound or soluble form of 4-1BBL, and compared with the agonistic anti-4-1BB Ab for their ability to adjuvant the Gag DNA vaccine. Both, anti-4-1BB agonistic Ab as well as 4-1BBL DNA enhanced the Gag-specific cellular immune responses. However, in complete contrast to the agonistic Ab that suppressed humoral immunity to Gag, 4-1BBL DNA adjuvanted vaccines enhanced Gag-specific IgG responses. Importantly, the expression of Gag and 4-1BBL from the same plasmid was critical for the adjuvant activity. Collectively, our data suggest that for a HIV-1 vaccine where both antigen-specific cellular and humoral immunity are desirable, 4-1BBL expressed by a DNA vaccine is a superior adjuvant than anti-4-1BB agonistic Ab. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944789      PMCID: PMC2814905          DOI: 10.1016/j.vaccine.2009.11.020

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  34 in total

Review 1.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

2.  Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis.

Authors:  Yonglian Sun; Xiaoqi Lin; Helen M Chen; Qiang Wu; Sumit K Subudhi; Lieping Chen; Yang-Xin Fu
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity.

Authors:  David Cooper; Pratima Bansal-Pakala; Michael Croft
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

4.  4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.

Authors:  J L Cannons; P Lau; B Ghumman; M A DeBenedette; H Yagita; K Okumura; T H Watts
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

5.  Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154.

Authors:  L E Haswell; M J Glennie; A Al-Shamkhani
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

6.  4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.

Authors:  J T Tan; J K Whitmire; K Murali-Krishna; R Ahmed; J D Altman; R S Mittler; A Sette; T C Pearson; C P Larsen
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

7.  Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand.

Authors:  I Gramaglia; D Cooper; K T Miner; B S Kwon; M Croft
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

8.  CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes.

Authors:  G Kienzle; J von Kempis
Journal:  Int Immunol       Date:  2000-01       Impact factor: 4.823

9.  Temporal segregation of 4-1BB versus CD28-mediated costimulation: 4-1BB ligand influences T cell numbers late in the primary response and regulates the size of the T cell memory response following influenza infection.

Authors:  Edward M Bertram; Peggy Lau; Tania H Watts
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

10.  Cutting edge: Expression of functional CD137 receptor by dendritic cells.

Authors:  Ryan A Wilcox; Andrei I Chapoval; Kevin S Gorski; Mizuto Otsuji; Tahiro Shin; Dallas B Flies; Koji Tamada; Robert S Mittler; Haruo Tsuchiya; Drew M Pardoll; Lieping Chen
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

View more
  11 in total

1.  Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Authors:  Saravana K Kanagavelu; Victoria Snarsky; James M Termini; Sachin Gupta; Suzanne Barzee; Jacqueline A Wright; Wasif N Khan; Richard S Kornbluth; Geoffrey W Stone
Journal:  Vaccine       Date:  2011-12-04       Impact factor: 3.641

2.  Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.

Authors:  Venkateswarlu Chamcha; Andrew Jones; Bernard R Quigley; June R Scott; Rama Rao Amara
Journal:  J Immunol       Date:  2015-10-19       Impact factor: 5.422

Review 3.  Costimulatory molecules as vaccine adjuvants: to 4-1BB or not to 4-1BB?

Authors:  Khalidur Rahman; Smita S Iyer
Journal:  Cell Mol Immunol       Date:  2014-09-08       Impact factor: 11.530

4.  Soluble expression of recombinant human CD137 ligand in Escherichia coli by co-expression of chaperones.

Authors:  Shuzhen Wang; Aimin Tan; Junfang Lv; Peng Wang; Xiaojin Yin; Yijun Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2011-10-15       Impact factor: 3.346

5.  Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens.

Authors:  Yuan Zhao; Vikas Tahiliani; Shahram Salek-Ardakani; Michael Croft
Journal:  Front Immunol       Date:  2012-11-08       Impact factor: 7.561

6.  Recombinant Salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL.

Authors:  Jianxin Ye; Ling Li; Yuanting Zhang; Xueguang Zhang; Daming Ren; Weichang Chen
Journal:  J Biomed Sci       Date:  2013-02-17       Impact factor: 8.410

7.  Adenovirus type 5 induces vitamin A-metabolizing enzymes in dendritic cells and enhances priming of gut-homing CD8 T cells.

Authors:  S Ganguly; S Manicassamy; J Blackwell; B Pulendran; R R Amara
Journal:  Mucosal Immunol       Date:  2011-02-02       Impact factor: 7.313

8.  Gene silencing of 4-1BB by RNA interference inhibits acute rejection in rats with liver transplantation.

Authors:  Yang Shi; Shuqun Hu; Qingwei Song; Shengcai Yu; Xiaojun Zhou; Jun Yin; Lei Qin; Haixin Qian
Journal:  Biomed Res Int       Date:  2013-01-31       Impact factor: 3.411

9.  HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity.

Authors:  Saravana Kanagavelu; James M Termini; Sachin Gupta; Francesca N Raffa; Katherine A Fuller; Yaelis Rivas; Sakhi Philip; Richard S Kornbluth; Geoffrey W Stone
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.

Authors:  Douglas C Macdonald; Alastair Hotblack; Saniath Akbar; Gary Britton; Mary K Collins; William C Rosenberg
Journal:  J Immunol       Date:  2014-10-10       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.